Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 27, 2015 | March 03, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 27, 2015 · Filed March 03, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 108,972 |
Reported balance
After 2015-02-27 transaction · row 1
1 source rowRow 1 · 2015-02-27 · Tax withholding · Disposed 11,530 · Balance 108,972 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 18,963 |
Reported balance
Holding disclosure · report date 2015-02-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 18,963 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 171 |
Reported balance
Holding disclosure · report date 2015-02-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 171 F2: The reporting person disclaims beneficial ownership of all securities held by his son. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2015.
F2: The reporting person disclaims beneficial ownership of all securities held by his son.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 11,383 | $34.77 | $395,817.64 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 637 | $43.49 | $27,703.13 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,986 Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 15,409 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,409 Underlying: common shares · 15,409 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 18,231 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 18,231 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,409 | $42.83 | $659,967.47 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,623 Read SEC document |
| February 14, 2006 Filed Feb 17, 2006 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 18,231 | $33.23 | $605,841.65 |
DisclosureSEC source: 0001104659-06-010253 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 21,102 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · derivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,102 Underlying: Common shares · 21,102 shares Expires 2013-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 24,807 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · derivative · entry 7 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,281 Underlying: Common shares · 24,807 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 21,102 | $42.42 | $895,146.84 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,801 Read SEC document |
| February 07, 2006 Filed Feb 9, 2006 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 24,807 | $33.23 | $824,371.34 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2005 Filed Feb 9, 2006 21:36 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-007423 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,096 Read SEC document |
| November 01, 2005 Filed Nov 3, 2005 19:53 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 3,453 | $43.00 | $148,479.00 |
DisclosureSEC source: 0001104659-05-052280 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,465 Read SEC document |
| May 25, 2005 Filed Aug 4, 2005 14:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 18,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-036273 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Ann Marie Landgraf Living Trust Disclosed balance after: 20,000 F1 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. Read SEC document |
| May 25, 2005 Filed Aug 4, 2005 14:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 18,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-036273 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,918 Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 63,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008015 · a4.xml · derivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,800 Underlying: common shares · 63,800 shares Expires 2015-02-17 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:50 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 9,300 | $46.34 | $430,962.00 |
DisclosureSEC source: 0001104659-05-008015 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,368 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Disposition to issuerOption (right to buy) · Derivative | 9,221 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 9,221 shares Expires 2005-04-27 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 5,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 6 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Anne Marie Landgraf Living Trust Disclosed balance after: 38,550 F1 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. 27,477 of the shares held by the trust were previously incorrectly reported as being directly owned by the reporting person. Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 5,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,068 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 3,706 | $45.75 | $169,549.50 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,583 Read SEC document |
| January 21, 2005 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 9,221 | $18.39 | $169,591.71 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 14,699 | $0.00 Strike: $46.42 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,699 Underlying: common shares · 14,699 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,357 | $0.00 Strike: $46.42 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,357 Underlying: common shares · 11,357 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Disposition to issuerOption (right to buy) · Derivative | 3,074 | $0.00 Strike: $45.47 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,074 shares Expires 2005-04-27 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Disposition to issuerOption (right to buy) · Derivative | 17,754 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 9 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,088 Underlying: common shares · 17,754 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Disposition to issuerOption (right to buy) · Derivative | 13,852 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · derivative · entry 8 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,065 Underlying: common shares · 13,852 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 29,092 | $46.42 | $1,350,450.64 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,103 Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,074 | $45.47 | $139,781.85 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 4 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 17,754 | $33.23 | $589,990.28 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 13,852 | $32.61 | $451,728.96 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2004 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 5,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 5 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Anne Marie Landgraf Living Trust Disclosed balance after: 33,035 F1 · balance_after: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse. 27,477 of the shares held by the trust were previously incorrectly reported as being directly owned by the reporting person. Read SEC document |
| December 21, 2004 Filed Jan 26, 2005 00:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 5,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-002542 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,068 Read SEC document |
| November 26, 2004 Filed Dec 23, 2004 00:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-040984 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,515 Read SEC document |
| August 03, 2004 Filed Aug 5, 2004 18:54 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $39.26 | $0.00 |
DisclosureSEC source: 0001104659-04-022634 · a4.xml · derivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: common shares · 25,000 shares Expires 2014-08-02 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,334 on 8/03/05, 8,333 on 8/3/06 and 8,333 on 8/3/07. Read SEC document |
| August 01, 2004 Filed Aug 3, 2004 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,500 | $39.24 | $137,340.00 |
DisclosureSEC source: 0001104659-04-021963 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,805 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.